MFG
HQL

Merit Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History

Merit Financial Group’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Buy
13,076
+423
+3% +$7.47K ﹤0.01% 1907
2026
Q1 		$206K Buy
12,653
+1,403
+12% +$23.4K ﹤0.01% 1908
2025
Q4 		$189K Buy
11,250
+453
+4% +$7.61K ﹤0.01% 1836
2025
Q3 		$167K Buy
10,797
+582
+6% +$7.97K ﹤0.01% 1700
2025
Q2 		$131K Buy
+10,215
New +$126K ﹤0.01% 1612

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Merit Financial Group's HQL Position: Q2 2026 in Review

Merit Financial Group increased its abrdn Life Sciences Investors (HQL) stake by 3.3% in Q2 2026, buying an estimated $7.47K and bringing the position to 13,076 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

Merit Financial Group first reported a position in HQL in Q2 2025 and has held it in 5 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Merit Financial Group held 13,076 shares of abrdn Life Sciences Investors worth $262K as of Q2 2026.
  • Merit Financial Group bought 423 abrdn Life Sciences Investors shares in Q2 2026, an estimated $7.47K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1907 holding.
  • Merit Financial Group first reported a position in abrdn Life Sciences Investors in Q2 2025 and has held it in 5 quarters since.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.